SILENCE THERAPEUTICS PLC revenue breakdown overview

SILENCE THERAPEUTICS PLC revenue for the last year amounted to 41.40 M EUR, the most of which — 41.79 M EUR — came from its highest performing source at the moment, Ribonucleic Acid Therapeutics, the year earlier bringing 28.58 M EUR. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought SILENCE THERAPEUTICS PLC 41.65 M EUR, and the year before that — 27.94 M EUR.